News
JNDOF
22.75
NaN%
--
JINS HOLDINGS Reports Strong November Sales Growth and Store Expansion
TipRanks · 1d ago
JINS HOLDINGS Announces Key Executive Restructuring
TipRanks · 11/27 07:31
JINS HOLDINGS Reports Strong Sales Growth and Store Expansion in October 2025
TipRanks · 11/06 08:24
JINS HOLDINGS Proposes Amendments to Articles of Incorporation
TipRanks · 10/29 07:28
JINS HOLDINGS Announces Year-End Dividend of 59 Yen Per Share
TipRanks · 10/29 07:27
JINS HOLDINGS Reports Strong Growth in 2025 Earnings
Barchart · 10/11 22:58
JINS HOLDINGS Exceeds Financial Forecasts and Raises Dividend
Barchart · 10/11 02:26
JINS HOLDINGS Reports Strong Financial Growth and Increased Dividends for FY2025
Barchart · 10/11 02:26
JINS HOLDINGS Expands Operations with New Philippine Subsidiary
Barchart · 10/10 02:24
JINS HOLDINGS Reports Strong Sales Growth in September 2025
Barchart · 10/04 02:38
UBS Sticks to Its Hold Rating for JINS HOLDINGS (JNDOF)
TipRanks · 09/08 10:25
JINS HOLDINGS Sees Strong Sales Growth in August 2025
TipRanks · 09/05 07:22
JINS HOLDINGS Announces Leadership Transition to Drive Sustainable Growth
TipRanks · 08/29 06:58
JINS HOLDINGS Reports Strong July Sales Growth
TipRanks · 08/05 07:37
JINS HOLDINGS Reports Strong Growth in 2025 Earnings
TipRanks · 07/12 03:52
More
Webull provides a variety of real-time JNDOF stock news. You can receive the latest news about Jins Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About JNDOF
Jins Holdings Inc is a Japan-based company mainly engaged in the retail of eyeglasses. The Company operates through two business segments. The Domestic Eyewear Business segment and the Overseas Eyewear Business segment mainly sell eyeglasses and other products, with local subsidiaries in each country selling eyeglasses and other products in stores and online. The Company is also involved in the planning, development, manufacturing, processing, sales, rental, maintenance, import and export of wearable devices and related products, as well as the sale, import, and export of pharmaceuticals and related products.